A Comprehensive Review on DNA Gyrase Inhibitors.
| Autor: | Chitra SR; Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai -97, India., Ramalakshmi N; Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai -97, India., Arunkumar S; College of Pharmacy, Gulf Medical University, Ajmaan, United Arab Emirates., Manimegalai P; Department of Pharmaceutical Chemistry, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai -97, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Infectious disorders drug targets [Infect Disord Drug Targets] 2020; Vol. 20 (6), pp. 765-777. |
| DOI: | 10.2174/1871526520666200102110235 |
| Abstrakt: | The newly emerging infectious organisms, the global crisis in antibiotic resistance, and the threat of bioterrorism create an urgent need to discover novel antimicrobial agents. In order to develop novel antimicrobial agents, the mechanism of infectious disease must be better understood. DNA Gyrase is a bacterial enzyme that plays an important role in the replication of DNA and transcription process. It is not present in higher eukaryotes making it a perfect target for developing new antibacterial agents. This review describes the role of DNA gyrase inhibitors in preventing various diseases. In this review, we outline the synthesis and pharmacological action of various novel DNA gyrase inhibitors. DNA gyrase inhibitors were used to treat tuberculosis, bacterial, fungal infections and malaria. DNA gyrase inhibitors mainly act by preventing the supercoiling of DNA strands.. (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|